Veröffentlichungen

Myeloid transformation by MLL-ENL depends strictly on C/EBP

R. Wesolowski
E. Kowenz-Leutz
K. Zimmermann
D. Dörr
M. Hofstätter
R.K. Slany
A. Mildner
A. Leutz

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

S. Reinke
P.J. Bröckelmann
I. Iaccarino
M. Garcia-Marquez
S. Borchmann
F. Jochims
M. Kotrova
K. Pal
M. Brüggemann
E. Hartmann
S. Sasse
C. Kobe
S. Mathas
M. Soekler
U. Keller
M. Bormann
A. Zimmermann
J. Richter
M. Fuchs
B. von Tresckow
P. Borchmann
H. Schlößer
M. von Bergwelt-Baildon
A. Rosenwald
A. Engert
W. Klapper

Proteomic analysis reveals upregulation of ACE2, the putative SARS-CoV-2 receptor in pressure- but not volume-overloaded human hearts

J. Stegbauer
M. Kraus
S. Nordmeyer
M. Kirchner
M. Ziehm
H. Dommisch
S. Kelle
M. Kelm
I. Baczko
U. Landmesser
C. Tschope
C. Knosalla
M. Falcke
M.P. Schapranow
V. Regitz-Zagrosek
P. Mertins
T. Kuehne

Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial

P.J. Bröckelmann
H. Goergen
U. Keller
J. Meissner
R. Ordemann
T.V. Halbsguth
S. Sasse
M. Sökler
A. Kerkhoff
S. Mathas
A. Hüttmann
M. Bormann
A. Zimmermann
J. Mettler
M. Fuchs
B. von Tresckow
C. Baues
A. Rosenwald
W. Klapper
C. Kobe
P. Borchmann
A. Engert

Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma

B. Edginton-White
P. Cauchy
S.A. Assi
S. Hartmann
A.G. Riggs
S. Mathas
P.N. Cockerill
C. Bonifer

PRISMA: Protein Interaction Screen on Peptide Matrix reveals interaction footprints and modifications- dependent interactome of intrinsically disordered C/EBPb

G. Dittmar
D. Perez Hernandez
E. Kowenz-Leutz
M. Kirchner
G. Kahlert
R. Wesolowski
K. Baum
M. Knoblich
M. Hofstätter
A. Muller
J. Wolf
U. Reimer
A. Leutz

Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma

L. von Hoff
E. Kärgel
V. Franke
E. McShane
K.W. Schulz-Beiss
G. Patone
N. Schleussner
M. Kolesnichenko
N. Hübner
O. Daumke
M. Selbach
A. Akalin
S. Mathas
C. Scheidereit

On the relation between filament density, force generation and protrusion rate in mesenchymal cell motility

S. Dolati
F. Kage
J. Mueller
M. Müsken
M. Kirchner
G. Dittmar
M. Sixt
K. Rottner
M. Falcke

01. September 2018 in Leukemia

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

N. Schleussner
O. Merkel
M. Costanza
H.C. Liang
F. Hummel
C. Romagnani
P. Durek
I. Anagnostopoulos
M. Hummel
K. Jöhrens
A. Niedobitek
P.R. Griffin
R. Piva
H.L. Sczakiel
W. Woessmann
C. Damm-Welk
C. Hinze
D. Stoiber
B. Gillissen
S.D. Turner
E. Kaergel
L. von Hoff
M. Grau
G. Lenz
B. Dörken
C. Scheidereit
L. Kenner
M. Janz
S. Mathas

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group

D.A. Eichenauer
A. Plütschow
S. Kreissl
M. Sökler
J.C. Hellmuth
J. Meissner
S. Mathas
M.S. Topp
K. Behringer
W. Klapper
G. Kuhnert
M. Dietlein
C. Kobe
M. Fuchs
V. Diehl
A. Engert
P. Borchmann